4D Molecular Therapeutics, Inc. (FDMT): SCHEDULE 13G filed Oct 20, 2025

Form type

SCHEDULE 13G

Filing date

Oct 20, 2025

Accession number

0001388325-25-000011

Filer

4D Molecular Therapeutics, Inc. (CIK 1650648)